EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research

R Bissonnette iD, E Saint-Cyr Proulx, C Jack, C Maari

Journal of the European Academy of Dermatology and Venereology · 2023-06 · 37 (6) · 1168-1174

DOI: 10.1111/jdv.18925 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 13.02.2023. Verfasst von R Bissonnette und 3 weiteren Autor:innen. Beteiligte Einrichtung: Innovaderm Research Inc., Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Psoriasis, Stilbenes. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tapinarof is a topical, aryl‐hydrocarbon receptor agonist that has recently received FDA‐approval for the treatment of psoriasis. This novel therapeutic has also been shown to be effective for atopic dermatitis and is currently in phase 3 for this indication. Beyond good efficacy and fast onset of action in patients with psoriasis, the clinical response to tapinarof is notable for durable remission or near remission, maintained for an average of 130 days beyond treatment discontinuation in patients with psoriasis in phase 3 studies. Tapinarof is usually well tolerated but can induce a follicular inflammatory reaction and dermatitis in some patients. This narrative review covers the historical development of this molecule, safety and efficacy data from clinical trials conducted with various topical formulations, and practical considerations derived from our 15 years of clinical trial experience with the drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPsoriasisStilbenesHumansResorcinols

Substanzen

tapinarofResorcinolsStilbenes

Autor:innen und Institutionen

  • Innovaderm Research Inc., Montreal, Quebec, Canada.

ORCID-Profile: R Bissonnette

Zitieren

APA

Bissonnette, R., Saint-Cyr Proulx, E., Jack, C., & Maari, C. (2023). Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research. Journal of the European Academy of Dermatology and Venereology, 37(6), 1168-1174. https://doi.org/10.1111/jdv.18925

Vancouver

Bissonnette R, Saint-Cyr Proulx E, Jack C, Maari C. Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research. Journal of the European Academy of Dermatology and Venereology. 2023;37(6):1168-1174. doi:10.1111/jdv.18925

BibTeX
@article{Bissonnette2023,
  author = {Bissonnette, R and Saint-Cyr Proulx, E and Jack, C and Maari, C},
  title = {Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  volume = {37},
  number = {6},
  pages = {1168--1174},
  doi = {10.1111/jdv.18925}
}
Kostenlos starten →